Sarbajit Mukherjee

Dr. Sarbajit Mukherjee is the Chief of Gastrointestinal Medical Oncology at Miami Cancer Institute in Miami, FL. Dr. Mukherjee’s current work focuses on novel clinical trials in GI malignancies. He has conducted multiple investigator-initiated clinical trials as a principal investigator. Dr. Mukherjee has received peer-reviewed grants from the Department of Defense, National Comprehensive Cancer Network (NCCN), and North American Neuroendocrine Tumor Society. He has presented at many national and international conferences and has been published in high-impact journals like Nature Medicine and the Journal of Clinical Oncology. He has served on grant review panels through the NIH (National Institutes of Health) and the US FDA.

Dr. Mukherjee co-chairs the GI clinical trial working group at the Hoosier Cancer Research Network. He also serves as a board member at the Esophageal Cancer Action Network. Dr. Mukherjee served the American Society of Clinical Oncology (ASCO) as a member of the Trainee Council Working Group, the Clinical Practice Guidelines Committee, and the Professional Development Committee. He also served on multiple guidelines panels for ASCO, NCCN and the International Society of the Diseases of the Esophagus. He has received many awards, including membership in Alpha Omega Alpha Medical Honor Society and the Gold Humanism Honor Society. Dr. Mukherjee is invested in teaching and mentoring his junior colleagues and organizing and moderating educational and scientific meetings.

William S. Rilling, MD, FSIR, is a Tenured Professor of Radiology and Surgery at the Medical College of Wisconsin. He completed his diagnostic radiology residency at the Medical College of Wisconsin and his fellowship in Vascular and Interventional Radiology at Northwestern University in Chicago in 1996. He has been practicing at the Medical College of Wisconsin since 1996 and is the Vice Chair of Clinical Operations in Radiology and is also the former Division Chief of Vascular and Interventional Radiology, a role he held for 14 years.

Dr. Rilling has served on the Executive Council for the Society of Interventional Radiology (SIR), the Board of Directors for World Congress of Interventional Oncology (WCIO), SIR Foundation, and Society of Interventional Oncology (SIO). As Education Councilor for SIR, he co-directed the first three professional education meetings dedicated to Interventional Oncology, beginning in 2002. He has also served as the annual meeting chair for both SIR and WCIO and is the past-president for the Society of Interventional Oncology (SIO). He has served as local and national principal investigator for several important IO trials and is currently active as a consultant for several companies working to improve outcomes in IO.